Skip to main content
Erschienen in: Italian Journal of Pediatrics 1/2011

Open Access 01.12.2011 | Research

Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India

verfasst von: Ramesh Bhat Y, Leslie Edward S Lewis, Vandana KE

Erschienen in: Italian Journal of Pediatrics | Ausgabe 1/2011

Abstract

Background

Epidemiology and surveillance of neonatal sepsis helps in implementation of rational empirical antibiotic strategy.

Objective

To study the frequency of bacterial isolates of early onset neonatal sepsis (EONS) and their sensitivity pattern.

Methods

In this retrospective study, a case of EONS was defined as an infant who had clinical signs or born to mothers with potential risk factors for infection, in whom blood culture obtained within 72 hours of life, grew a bacterial pathogen. Blood culture sample included a single sample from peripheral vein or artery. Relevant data was obtained from the unit register or neonatal case records.

Results

Of 2182 neonates screened, there were 389 (17.8%) positive blood cultures. After excluding coagulase-negative Staphylococci (160), we identified 229 EONS cases. Preterm neonates were 40.6% and small for gestational age, 18.3%. Mean birth weight and male to female ratio were 2344.5 (696.9) g and 1.16:1 respectively. Gram negative species represented 90.8% of culture isolates. Pseudomonas (33.2%) and Klebsiella (31.4%) were common among them. Other pathogens included Acinetobacter (14.4%), Staphylococcus aureus (9.2%), E.coli (4.4%), Enterobacter (2.2%), Citrobacter (3.1%) and Enterococci (2.2%). In Gram negative group, best susceptibility was to Amikacin (74.5%), followed by other aminoglycosides, ciprofloxacin and cefotaxime. The susceptibility was remarkably low to ampicillin (8.4%). Gram positive group had susceptibility of 42.9% to erythromycin, 47.6% to ciprofloxacin and above 50% to aminoglycosides. Of all isolates, 83.8% were susceptible to either cefotaxime or amikacin

Conclusion

Gram-negative species especially Pseudomonas and Klebsiella were the predominant causative organisms. Initial empirical choice of cefotaxime in combination with amikacin appeared to be rational choice for a given cohort.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1824-7288-37-32) contains supplementary material, which is available to authorized users.

Authors' contributions

RB involved in study design, data collection, analysis, treatment of cases, manuscript preparation and draft. VKE involved in blood culture analysis, expert microbiological inputs and approval of the manuscript. LEL is involved in treatment of cases and manuscript preparation. All authors have read and approved the final manuscript.

Background

Early onset bacterial infection places the neonate at risk of death and long term morbidity [1-, 3]. Improvement in outcome and successful treatment depends on early initiation of appropriate antibiotic therapy. The pattern of causative organisms has been constantly changing [4] and the frequent emergence of resistant bacteria [5] compounds the problem further. This highlights the need for surveillance of sepsis for optimum therapy. Knowledge of likely causative organisms and their antimicrobial sensitivity pattern could aid in choosing prompt and appropriate therapy for early-onset neonatal sepsis (EONS). The epidemiology of EONS in the developed and developing countries shows some important differences in the pattern of etiological bacteria and their antibiotic susceptibility [13, 6, 7]. In developed countries, Group B Streptococcus (GBS) was the common etiological agent for EONS [6, 7]. Following adoption of preventive strategies for GBS, Escherichia coli (E.coli) was identified as predominant pathogen [7, 8]. Developing nations reported an entirely a different bacterial spectrum [3, 7, 911]. Current study was undertaken to find out the common bacterial pathogens and their susceptibility pattern in neonates with early onset sepsis in a tertiary care hospital providing neonatal intensive care services.

Methods

Present study was carried out in a neonatal unit of Kasturba Hospital, Kasturba Medical College, Manipal from January 1998 to December 2004. We retrospectively evaluated the case records of neonates who had EONS. A case of EONS was defined as an infant who had clinical signs of sepsis or those who were born to mothers with potential risk factors for infection, in whom blood culture obtained within 72 hours of life, grew a bacterial pathogen. Risk factors in the mother included prolonged rupture of membranes (PROM) of >12hours, fever, urinary tract infection, chorioamnionitis and meconium stained amniotic fluid. Blood culture sample included a single sample collected from a peripheral vein or artery under aseptic conditions. The local site was cleansed with 70% alcohol and povidone iodine (1%) followed by 70% alcohol again. Blood cultures were done in Brain Heart Infusion biphasic medium. Subcultures were done on Sheep blood agar and MacConkey agar at the earliest visual detection of turbidity or blindly on days 1, 4 and 7 if the bottles did not show turbidity. Gram's staining was performed on the bottles showing turbidity. Bacterial isolates were identified and antimicrobial susceptibility test was performed using Kirbey Bauer disc diffusion method. (Reference -National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests; Approved standard. 7th ed. NCCLS Document M2 - A7. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.) After obtaining blood for culture, the neonates were administered intravenous ampicillin and gentamicin as the first line of antibiotics. Antibiotic therapy was continued or changed, based on the isolation of organisms in the blood culture and their sensitivity pattern. Other neonatal intensive care and support were given as required. CSF analysis was done when there was clinical suspicion of meningitis and in whom blood culture grew microorganism. Urine and other cultures were obtained on indications. The demographic data, blood culture reports, organisms and their antibiotic susceptibility were obtained from the unit register and/or neonatal case records. Neonates with blood cultures that grew only coagulase-negative staphylococcus were excluded. Data was analyzed using Statistical Package for Social Sciences (SPSS) version 11.5 software.

Results

Of 2182 neonates screened for EONS, there were 389 (17.8%) positive blood cultures. After excluding growth of coagulase-negative Staphylococci (160 cases, 41.1%), we identified 229 cases of EONS. Both blood and CSF cultures were positive in 8(3.5%) cases. Demographic characteristics of 229 neonates were shown in Table 1. The male to female ratio was 1.16:1. The predisposing factors and comorbid conditions were shown in table 2. Obstetric risk factors and preterm delivery was present in 54.6% (125/229). Figure 1 shows the distribution of bacterial isolates from blood cultures. During the 7 years period, 208 (90.8%) sepsis cases were attributable to Gram negative species and 21 (9.2%) were attributable to Gram positive species. Pseudomonas spp (33.2% of all isolates, 36.5% of Gram-negatives) and Klebsiella pneumoniae (31.4% of all isolates, 34.6% of Gram-negative isolates) were the common isolates that accounted for nearly 2/3rd of total blood culture isolates. Acinetobacter spp (14.4%) was the third common organism. Staphylococcus aureus represented 9.2%( 21/229). Other pathogens included E.coli (10), Enterobacter spp (5), Citrobacter spp (7) and Enterococcus spp (5).
Table 1
Demographic characteristics (n = 229)
Birth weight, mean (SD)
2344.5(696.9) g
Male
123 (53.7%)
Female
106 (46.3%)
Term
136 (59.4%)
Preterm
93 (40.6%)
Small for gestational age
42 (18.3%)
Table 2
Predisposing factors and comorbidity among blood culture positive neonates (n = 229)
 
Number
%
1. Obstetric risk factors
  
   PROM
11
4.8
   Chorioamnionitis
8
3.5
   MSAF
13
5.7
2. Neonatal factors
  
   Prematurity alone
47
20.5
   Perinatal asphyxia
10
4.4
   RDS
14
6.1
   Respiratory distress
19
8.3
   MAS
38
16.6
   Meningitis
8
3.5
   Hypoglycemia
6
2.6
   Congenital malformations
13
5.7
PROM, prolonged rupture of membranes; MSAF, meconium stained amniotic fluid; RDS, respiratory distress syndrome; MAS, meconium aspiration syndrome.
Table 3 shows the antibiotic susceptibility pattern of different bacterial isolates. Pseudomonas species were mostly susceptible to amikacin, moderately to gentamicin, netilmicin and ciprofloxacin, and less susceptible to ceftazidime and piperacillin. Klebsiella and Acinetobacter species were more susceptible to amikacin and moderately to other aminoglycosides, third generation cephalosporins and ciprofloxacin. E.coli and other gram negative bacilli were susceptible to amikacin and netilmicin but remarkably less sensitive to ampicillin. S.aureus was better susceptible to erythromycin, ciprofloxacin, vancomycin and amikacin when compared to ampicillin and cefotaxime. All Enterococci were susceptible to vancomycin. There were three methicillin resistant Staphylococci and they were susceptible to vancomycin.
Table 3
Antibiotic susceptibility pattern of blood culture isolates (% susceptible)
 
Pseudomonas
Klebsiella
Acineto-bacter
S.aureus
E.coli
Entero-bacter
Citro-bacter
Entero-cocci
Ampicillin
NT
6.9
33.3
28.6
20
0
12.5
20
Gentamicin
56.6
25
48.5
61.9
40
0
25
20
Amikacin
76.3
77.8
66.7
76.2
70
100
50
NT
Netilmycin
56.6
31.9
66.7
52.4
30
40
75
NT
Tobramycin
26.3
6.9
33.3
NT
20
40
25
NT
TMP/SMX
NT
33.3
21.2
28.5
40
20
25
0
Ciprofloxacin
40.8
51.4
36.4
47.6
20
80
50
40
Piperacillin
23.7
NT
NT
NT
NT
NT
NT
NT
Vancomycin
NT
NT
NT
100
NT
NT
NT
100
Cefuroxime
NT
5.6
6.1
14.2
7
8
12.5
NT
Cefotaxime
NT
43
27.3
28.5
40
20
37.5
NT
Ceftazidime
14.5
45.8
36.3
NT
10
0
12.5
NT
Erythromycin
NT
NT
NT
42.9
NT
NT
NT
NT
'NT' means not tested.
In Gram negative group, best overall sensitivity was to amikacin (74.5%). Gram positive group had sensitivity of 42.9% to erythromycin, 47.6% to ciprofloxacin and above 50% to aminoglycosides (Table 3 and Table 4)
Table 4
Susceptibility (%) of gram positive and gram negative organism groups
 
Gram
negative
Gram
positive
Ampicillin
8.4
28.6
Gentamicin
40.4
65.3
Amikacin
74.5
61.7
Netilmycin
48.1
52.4
TMP/SMX
29.3
28.2
Ciprofloxacin
44.2
47.6
Vancomycin
100
100
Cefotaxime
32.7
28.5
Ceftazidime
27.9
NT
Piperacillin
23.7
NT
NT = not tested

Discussion

We conducted an audit of positive blood cultures obtained from neonates with EONS over 7 years. The blood culture yield was about 18%. This is low compared to about 20% yield reported by Baltimore et al [8] and Gladstone et al [12]. Earlier, culture positive rate of 26% by Ahmed et al [11] and much higher rates of 51% by Karthikeyan [13] and 64% by Tallur et al [14] were reported. We used conventional blood culture techniques in the present study. The automated systems like BacT alert may provide the results earlier and improve the yield [15]. Coagulase-negative Staphylococcus (CONS) has been identified as causative organism for EONS. In a study by Agarwal et al [16], approximately two third of CONS sepsis has developed within first three days of life. We excluded CONS from analysis because we used single blood sample for culture and it was difficult to analyse the response to antibiotics from the retrospective nature of the study, although discriminating true CONS infection from contamination, from single culture has been recognized [17]. Mothers received amoxicillin injections whenever indicated to reduce neonatal sepsis.
A male predominance was found in our study which agrees with previous reports [2, 11, 1820]. Among the neonates in whom blood culture was positive, prematurity and obstetric factors were present in 54.6% (125/229). Schuchat et al [21] found an obstetric risk factor-preterm delivery, intrapartum fever, or membrane rupture >/ = 18 hours in 49% of GBS and 79% of other sepsis. In an attempt to identify possible risk factors for EONS, Bizzarro et al [19] found preterm labor in 43%, fever before delivery in 26%, prolonged rupture of membranes in 46% and chorioamnionitis in 20%. A significant association of EONS with prolonged rupture of membranes and foul smelling liquor was found by Chacko and Sohi [3]. They also found among infants at risk of EOS, 20.6% developed sepsis compared to only 0.5% of those without these risk factors. Tallur et al [14] reported association of PROM > 24 hours in 14% and perinatal asphyxia in 22%. Association of meconium stained amniotic fluid with sepsis was identified by Kuruvilla et al [9]. Agarwal et al [16] found EONS more frequently in neonates with perinatal asphyxia.
Bacteria causing neonatal sepsis continue to change [410, 19, 22, 23]. They also differ from developed to developing country and place to place. In industrialized world GBS caused EONS predominantly [2, 6, 7, 21, 22, 24, 25]. E.coli was 2nd most common. Following GBS prophylaxis, decreasing incidence of GBS [5, 7, 8, 26] and increased rate of E.coli infections [5, 7, 8] have been reported. Significant proportions (50%-37%) of EONS due to gram positive organisms were reported from recent studies [68]. In contrast, 90.2% of isolates were gram negative species in the present study. Predominance of gram negative isolates (67.2%-92.5%) has been reported by developing countries [7, 8, 11, 18, 27].
Following GBS prophylaxis, industrialized countries identified E.coli as the predominant organism for EONS. Developing countries also identified E.coli as the most common causative organism [9, 10]. Rate of E.coli infection varied from 15.7%- 77.1%. Other studies from developing world found Klebsiella as the common organism [4, 14]. Rate of Klebsiella infection varies from 8.9%-64%. In contrast, we identified Pseudomonas species as the predominant isolates. Similar observations were reported by Joshi et al [18] and Tallur et al [14, 3]. Pseudomonas isolation rate varies from 8.9%-38.3%.
Acinetobacter accounted for 14.4% of EONS in our study. Infection rate up to 7.8% has been recognized [9, 11, 18]. Infection rates of other gram-negative organisms in the present study were similar to earlier reports [3, 9, 14]. The rate of S. aureus infection in the present study was 9.2%. Similar reports with rate of infection varying from 3.7%- 7% have been found previously [5, 10, 14]. However, Karthikeyan and Premkumar [13], in their analysis identified S aureus as a predominant pathogen (50% of EONS). A low rate of entrococci infection of present study is similar to the observations of Dobson and Baker [28].

Antibiotic susceptibility

In the present study, Pseudomonas species were best susceptible to amikacin, moderately to gentamicin, netilmicin and ciprofloxacin, and less susceptible to ceftazidime and piperacillin. Above 60% sensitivity of the organism to aminoglycoside is recognized [14]. Lower susceptibility to amikacin (45%) was found by Agarwal et al [16]. In contrast, Pseudomonas aeruginosa in a study with controlled antibiotic programs by Cordero et al [6] remained fully susceptible to ceftazidime and gentamicin. Klebsiella and Acinetobacter species of present study were more susceptible to amikacin and moderately to other aminoglycosides, third generation cephalosporins and ciprofloxacin. Higher sensitivity to aminoglycosides was reported by Agarwal et al [16] and Kuruvilla et al [9]. Low sensitivity to ampicillin is similar in all these studies.
E.coli and other gram negative bacilli were susceptible to amikacin and netilmicin but remarkably less sensitive to ampicillin. High sensitivity (up to 93.7%) of E.coli to amikacin [14, 16] and uniform susceptibility to cephalosporins have been described [14, 19]. Low sensitivity of E.coli to ampicillin in the present study is similar to many earlier studies [5, 14, 19, 21].
S.aureus of present study was better susceptible to erythromycin, ciprofloxacin, vancomycin and amikacin when compared to ampicillin and cefotaxime. Staphylococcal resistance of 79.3% to ampicillin [10] and low sensitivity to all commonly used antibiotics [13] were described in the literature. Susceptibility of Enterococci in the present study to aminoglycoside is similar to the observations of Dobson and Baker [28].

Sensitivity of bacterial groups (Gram negative and Gram positive)

In the current study all isolates were best sensitive to amikacin while relatively less sensitive to other aminoglycosides. Good sensitivity of organisms to amikacin has been found by other researchers [10, 14, 16]. Some studies found good sensitivity to gentamicin [11, 29, 30]. The sensitivity was 17.5% to ampicillin. Cefotaxime had better sensitivity but only 32.3%. Low sensitivity of bacteria causing EONS to commonly used antibiotics has been found by other authors [10, 14, 19]. Tallur et al [14] reported that most isolates were resistant to ampicillin, gentamicin and cotrimaxazole. Ampicillin resistance of all Klebsiella isolates was reported by Thaver et al [31]. In contrast, good response to ampicillin has been found by Cordero et al [6] and to ampicillin-sulbactum by Mokuolu [27]. No increase in ampicillin resistant organisms following intrapartum antibiotics prophylaxis has also been reported [32]. Gram negative group had best overall sensitivity to Amikacin (74.5%), followed by other aminoglycosides and ciprofloxacin. Cephalosporins had low sensitivity. Higher sensitivity of gram negative group to gentamicin and ceftazidime has been reported by Mokuolu [27] and good sensitivity to cephalosporins by others [11, 14]. Meropenem sensitivity was tested since 2003. Gram negative organisms were universally susceptible to meropenem.
Of all isolates, 83.8% (192/229) were sensitive to either cefotaxime or amikacin and hence using this combination as the initial choice while awaiting blood culture reports seems reasonable. However, these results are limited to study cohorts and every center should have its own control on their bacterial strains.

Conclusion

Bacterial spectrum for EONS could be different in developed and developing countries. Continued surveillance of neonatal sepsis is mandatory for each center due to temporal changes in the causative organisms and their antibiotic susceptibility. Periodic evaluations not only show the trend of increasing resistance to commonly used antibiotics but also help in implementation of a rational empirical treatment strategy. Present study indicated that Gram-negative species continue to be the predominant causative organisms among study cohorts. Pseudomonas and Klebsiella played a major role and, Acinetobacter, Staphylococci and E.coli contributed to the rest. A low susceptibility to commonly used antibiotics like ampicillin is a cause for concern. The antibiotic susceptibility profiles suggested that for a given cohort, initial empirical choice of cefotaxime in combination with amikacin was the most rational.

Conflicts of interest

Authors declare that they have no conflicts of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Authors' contributions

RB involved in study design, data collection, analysis, treatment of cases, manuscript preparation and draft. VKE involved in blood culture analysis, expert microbiological inputs and approval of the manuscript. LEL is involved in treatment of cases and manuscript preparation. All authors have read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Stoll BJ, Holman RC, Schuchat A: Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics. 1998, 102: 1-7. 10.1542/peds.102.1.1.CrossRef Stoll BJ, Holman RC, Schuchat A: Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics. 1998, 102: 1-7. 10.1542/peds.102.1.1.CrossRef
2.
Zurück zum Zitat Stoll BJ, Gordon T, Korones S: Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1996, 129: 72-80. 10.1016/S0022-3476(96)70192-0.CrossRefPubMed Stoll BJ, Gordon T, Korones S: Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1996, 129: 72-80. 10.1016/S0022-3476(96)70192-0.CrossRefPubMed
3.
Zurück zum Zitat Chacko B, Sohi I: Early onset neonatal sepsis. Indian J Pediatr. 2005, 72: 23-26. 10.1007/BF02760574.CrossRefPubMed Chacko B, Sohi I: Early onset neonatal sepsis. Indian J Pediatr. 2005, 72: 23-26. 10.1007/BF02760574.CrossRefPubMed
4.
Zurück zum Zitat Daoud AS, Abuekteish F, Obeidat A, Al-Nassir Z, Al-Rimawi H: The changing face of neonatal septicaemia. Ann Trop Paediatr. 1995, 15: 93-96.PubMed Daoud AS, Abuekteish F, Obeidat A, Al-Nassir Z, Al-Rimawi H: The changing face of neonatal septicaemia. Ann Trop Paediatr. 1995, 15: 93-96.PubMed
5.
Zurück zum Zitat Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A: Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002, 110: 690-695. 10.1542/peds.110.4.690.CrossRefPubMed Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A: Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002, 110: 690-695. 10.1542/peds.110.4.690.CrossRefPubMed
6.
Zurück zum Zitat Cordero L, Sananes M, Ayers LW: Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect Control Hosp Epidemiol. 1999, 20: 242-246. 10.1086/501619.CrossRefPubMed Cordero L, Sananes M, Ayers LW: Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect Control Hosp Epidemiol. 1999, 20: 242-246. 10.1086/501619.CrossRefPubMed
7.
Zurück zum Zitat Ganatra HA, Stoll BJ, Zaidi AK: International perspective on early-onset neonatal sepsis. Clin Perinatol. 2010, 37: 501-523. 10.1016/j.clp.2010.02.004.CrossRefPubMed Ganatra HA, Stoll BJ, Zaidi AK: International perspective on early-onset neonatal sepsis. Clin Perinatol. 2010, 37: 501-523. 10.1016/j.clp.2010.02.004.CrossRefPubMed
8.
Zurück zum Zitat Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brein KL: Early-onset neonatal sepsis in the era of group B Streptococcal prevention. Pediatrics. 2001, 108: 1094-1098. 10.1542/peds.108.5.1094.CrossRefPubMed Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brein KL: Early-onset neonatal sepsis in the era of group B Streptococcal prevention. Pediatrics. 2001, 108: 1094-1098. 10.1542/peds.108.5.1094.CrossRefPubMed
9.
Zurück zum Zitat Kuruvilla KA, Pillai S, Jesudason M, Jana AK: Bacterial profile of sepsis in a neonatal unit in south India. Indian Pediatr. 1998, 35: 851-858.PubMed Kuruvilla KA, Pillai S, Jesudason M, Jana AK: Bacterial profile of sepsis in a neonatal unit in south India. Indian Pediatr. 1998, 35: 851-858.PubMed
10.
Zurück zum Zitat Aurangzeb B, Hameed A: Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns. J Coll Physicians Surg Pak. 2003, 13: 629-632.PubMed Aurangzeb B, Hameed A: Neonatal sepsis in hospital-born babies: bacterial isolates and antibiotic susceptibility patterns. J Coll Physicians Surg Pak. 2003, 13: 629-632.PubMed
11.
Zurück zum Zitat Ahmed NU, Chowdhury MA, Hoque M, Darmstadt GL: Clinical and bacteriological profile of neonatal septicemia in a tertiary level pediatric hospital in Bangladesh. Indian Pediatr. 2002, 39: 1034-1039.PubMed Ahmed NU, Chowdhury MA, Hoque M, Darmstadt GL: Clinical and bacteriological profile of neonatal septicemia in a tertiary level pediatric hospital in Bangladesh. Indian Pediatr. 2002, 39: 1034-1039.PubMed
12.
Zurück zum Zitat Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS: A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990, 9: 819-825. 10.1097/00006454-199011000-00009.CrossRefPubMed Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS: A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990, 9: 819-825. 10.1097/00006454-199011000-00009.CrossRefPubMed
13.
Zurück zum Zitat Karthikeyan G, Premkumar K: Neonatal sepsis: Staphylococcus aureus as the predominant pathogen. Indian J Pediatr. 2001, 68: 715-717. 10.1007/BF02752407.CrossRefPubMed Karthikeyan G, Premkumar K: Neonatal sepsis: Staphylococcus aureus as the predominant pathogen. Indian J Pediatr. 2001, 68: 715-717. 10.1007/BF02752407.CrossRefPubMed
14.
Zurück zum Zitat Tallur SS, Kasturi AV, Nadgir SD, Krishna BVS: Clinico-bacteriological study of neonatal septicemia in Hubli. Indian J Pediatr. 2000, 67: 169-174. 10.1007/BF02723654.CrossRefPubMed Tallur SS, Kasturi AV, Nadgir SD, Krishna BVS: Clinico-bacteriological study of neonatal septicemia in Hubli. Indian J Pediatr. 2000, 67: 169-174. 10.1007/BF02723654.CrossRefPubMed
15.
Zurück zum Zitat Garcia-Prats JA, Cooper TR, Schneider VF, Stager CE, Hansen TN: Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics. 2000, 105: 523-527. 10.1542/peds.105.3.523.CrossRefPubMed Garcia-Prats JA, Cooper TR, Schneider VF, Stager CE, Hansen TN: Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics. 2000, 105: 523-527. 10.1542/peds.105.3.523.CrossRefPubMed
16.
Zurück zum Zitat Agrawal M, Chaturvedi P, Dev SK, Narang P: Coagulase negative staphylococcal septicemia in newborns. Indian Pediatr. 1990, 27: 163-169.PubMed Agrawal M, Chaturvedi P, Dev SK, Narang P: Coagulase negative staphylococcal septicemia in newborns. Indian Pediatr. 1990, 27: 163-169.PubMed
17.
Zurück zum Zitat Huang YC, Wang YH, Chou YH, Lien RI: Significance of coagulase-negative Staphylococci isolated from a single blood culture from neonates in intensive care. Ann Trop Paediatr. 2006, 26: 311-318. 10.1179/146532806X152836.CrossRefPubMed Huang YC, Wang YH, Chou YH, Lien RI: Significance of coagulase-negative Staphylococci isolated from a single blood culture from neonates in intensive care. Ann Trop Paediatr. 2006, 26: 311-318. 10.1179/146532806X152836.CrossRefPubMed
18.
Zurück zum Zitat Joshi SG, Ghole VS, Niphadkar KB: Neonatal gram-negative bacteremia. Indian J Pediatr. 2000, 67: 27-32. 10.1007/BF02802632.CrossRefPubMed Joshi SG, Ghole VS, Niphadkar KB: Neonatal gram-negative bacteremia. Indian J Pediatr. 2000, 67: 27-32. 10.1007/BF02802632.CrossRefPubMed
19.
Zurück zum Zitat Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG: Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics. 2005, 116: 595-602. 10.1542/peds.2005-0552.CrossRefPubMed Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG: Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics. 2005, 116: 595-602. 10.1542/peds.2005-0552.CrossRefPubMed
20.
Zurück zum Zitat Dutta S, Reddy R, Sheikh S, Kalra J, Ray P, Narang A: Intrapartum antibiotics and risk factors for early onset sepsis. Arch Dis Child Fetal Neonatal Ed. 2010, 95: F99-103. 10.1136/adc.2009.163220.CrossRefPubMed Dutta S, Reddy R, Sheikh S, Kalra J, Ray P, Narang A: Intrapartum antibiotics and risk factors for early onset sepsis. Arch Dis Child Fetal Neonatal Ed. 2010, 95: F99-103. 10.1136/adc.2009.163220.CrossRefPubMed
21.
Zurück zum Zitat Schuchat A, Zywicki SS, Dinsmoor MJ: Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case control study. Pediatrics. 2000, 105: 21-26. 10.1542/peds.105.1.21.CrossRefPubMed Schuchat A, Zywicki SS, Dinsmoor MJ: Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case control study. Pediatrics. 2000, 105: 21-26. 10.1542/peds.105.1.21.CrossRefPubMed
22.
Zurück zum Zitat Ho LY: Sepsis in young infants. Rational approach to early diagnosis and treatment. Singapore Med J. 1992, 33: 119-122.PubMed Ho LY: Sepsis in young infants. Rational approach to early diagnosis and treatment. Singapore Med J. 1992, 33: 119-122.PubMed
23.
Zurück zum Zitat Seale AC, Mwaniki M, Newton CR, Berkley JA: Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis. 2009, 9: 428-438. 10.1016/S1473-3099(09)70172-0.PubMedCentralCrossRefPubMed Seale AC, Mwaniki M, Newton CR, Berkley JA: Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis. 2009, 9: 428-438. 10.1016/S1473-3099(09)70172-0.PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Hall RT, Kurth CG, Hall SL: Ten-year survey of positive blood cultures among admissions to a neonatal intensive care unit. J Perinatol. 1987, 7: 122-126.PubMed Hall RT, Kurth CG, Hall SL: Ten-year survey of positive blood cultures among admissions to a neonatal intensive care unit. J Perinatol. 1987, 7: 122-126.PubMed
25.
Zurück zum Zitat Jiang JH, Chiu NC, Huang FY: Neonatal sepsis in the neonatal intensive care unit: characteristics of early versus late onset. J Microbiol Immunol Infect. 2004, 37: 301-306.PubMed Jiang JH, Chiu NC, Huang FY: Neonatal sepsis in the neonatal intensive care unit: characteristics of early versus late onset. J Microbiol Immunol Infect. 2004, 37: 301-306.PubMed
26.
Zurück zum Zitat Isaacs D, Royle JA: Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Pediatr Infect Dis J. 1999, 18: 524-528. 10.1097/00006454-199906000-00009.CrossRefPubMed Isaacs D, Royle JA: Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Pediatr Infect Dis J. 1999, 18: 524-528. 10.1097/00006454-199906000-00009.CrossRefPubMed
27.
Zurück zum Zitat Mokuolu AO, Jiya N, Adesiyun OO: Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern. Afr J Med Med Sci. 2002, 31: 127-130.PubMed Mokuolu AO, Jiya N, Adesiyun OO: Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern. Afr J Med Med Sci. 2002, 31: 127-130.PubMed
28.
Zurück zum Zitat Dobson SRM, Baker CJ: Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics. 1990, 85: 165-171.PubMed Dobson SRM, Baker CJ: Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics. 1990, 85: 165-171.PubMed
29.
Zurück zum Zitat Levy I, Leibovici L, Drucker M, Samra Z, Konisberger H, Ashkenazi S: A prospective study of gram-negative bacteremia in children. Pediatr Infect Dis J. 1996, 15: 117-122. 10.1097/00006454-199602000-00006.CrossRefPubMed Levy I, Leibovici L, Drucker M, Samra Z, Konisberger H, Ashkenazi S: A prospective study of gram-negative bacteremia in children. Pediatr Infect Dis J. 1996, 15: 117-122. 10.1097/00006454-199602000-00006.CrossRefPubMed
30.
Zurück zum Zitat Darmstadt GL, Batra M, Zaidi AK: Parenteral antibiotics for the treatment of serious neonatal bacterial infections in developing country settings. Pediatr Infect Dis J. 2009, 28: S37-42. 10.1097/INF.0b013e31819588c3.CrossRefPubMed Darmstadt GL, Batra M, Zaidi AK: Parenteral antibiotics for the treatment of serious neonatal bacterial infections in developing country settings. Pediatr Infect Dis J. 2009, 28: S37-42. 10.1097/INF.0b013e31819588c3.CrossRefPubMed
31.
Zurück zum Zitat Thaver D, Ali SA, Zaidi AK: Antimicrobial resistance among neonatal pathogens in developing countries. Pediatr Infect Dis J. 2009, 28: S19-21. 10.1097/INF.0b013e3181958780.CrossRefPubMed Thaver D, Ali SA, Zaidi AK: Antimicrobial resistance among neonatal pathogens in developing countries. Pediatr Infect Dis J. 2009, 28: S19-21. 10.1097/INF.0b013e3181958780.CrossRefPubMed
32.
Zurück zum Zitat Puopolo KM, Eichenwald EC: No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics. 2010, 125: e1031-1038. 10.1542/peds.2009-1573.CrossRefPubMed Puopolo KM, Eichenwald EC: No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics. 2010, 125: e1031-1038. 10.1542/peds.2009-1573.CrossRefPubMed
Metadaten
Titel
Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India
verfasst von
Ramesh Bhat Y
Leslie Edward S Lewis
Vandana KE
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
Italian Journal of Pediatrics / Ausgabe 1/2011
Elektronische ISSN: 1824-7288
DOI
https://doi.org/10.1186/1824-7288-37-32

Weitere Artikel der Ausgabe 1/2011

Italian Journal of Pediatrics 1/2011 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.